Electroencephalographic study of pentazocine and buprenorphine.
Both pentazocine and buprenorphine are hypnoanalgetics of the agonistic-antagonist group. They suppress the inhibitory effect of fentanyl upon the central nervous system. They show also secondary their own inhibitory properties (fig. 8). The agonistic-antagonists can be further divided in excitants (like pentazocine) and non-excitants (buprenorphine).
D000818:Animals; D001921:Brain / Q000187:drug effects; D002047:Buprenorphine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D002415:Cats; D004569:Electroencephalography; D005283:Fentanyl / Q000037:antagonists & inhibitors / Q000494:pharmacology; D006801:Humans; D009019:Morphinans / Q000494:pharmacology*; D009020:Morphine / Q000494:pharmacology; D009270:Naloxone / Q000494:pharmacology; D009294:Narcotics / Q000494:pharmacology; D009619:Nociceptors / Q000032:analysis / Q000187:drug effects; D010423:Pentazocine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D011817:Rabbits; D013997:Time Factors
D009019:Morphinans; D009294:Narcotics; D009270:Naloxone; D002047:Buprenorphine; D009020:Morphine; D010423:Pentazocine; D005283:Fentanyl